Expertise in
6
conditions

Dr. Suzanne Gharib

Rheumatology
CAMC Rheumatology South Charleston
4610 Kanawha Ave SW Ste 301, 
South Charleston, WV 
Offers Telehealth
Referral may be required
Expertise in
6
conditions
CAMC Rheumatology South Charleston
4610 Kanawha Ave SW Ste 301, 
South Charleston, WV 

Overview

Suzanne Gharib is a Rheumatologist practicing medicine in South Charleston, West Virginia.

Dr. Gharib is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Psoriatic Arthritis.

She is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 6 clinical trials.

Specialties

Rheumatology

Licenses

Internal Medicine in WV

Hospital Affiliations

Charleston Area Medical Center
Camc Plateau Medical Center, Inc
Camden Clark Medical Center
Mon Health Medical Center
Stonewall Jackson Memorial Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

CAMC Rheumatology South Charleston
4610 Kanawha Ave SW Ste 301, South Charleston, WV 25309

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Enrollment Status: Completed
Publish Date: August 17, 2017
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

2 Total Publications

Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial.
Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial.
Journal: Annals of the rheumatic diseases
Published: September 30, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Wassim Saikali
Rheumatology
Expertise in
14
conditions
Dr. Wassim Saikali
Rheumatology
Referral may be required

Rheumatology And Pulmonary Clinic PLLC

421 Carriage Dr, 
Beckley, WV 
 (48.4 miles away)
304-256-0242
Languages Spoken:
English
See accepted insurances

Wassim Saikali is a Rheumatologist practicing medicine in Beckley, West Virginia. Dr. Saikali is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, and Fibromyalgia.

Expertise in
7
conditions
Dr. Michael Istfan
Rheumatology
Expertise in
7
conditions
Dr. Michael Istfan
Rheumatology
Referral may be required

CAMC Rheumatology South Charleston

4610 Kanawha Ave SW Ste 301, 
South Charleston, WV 
 (3.4 miles away)
304-720-8701
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Istfan is a Rheumatologist practicing medicine in South Charleston, West Virginia. Dr. Istfan is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Undifferentiated Connective Tissue Disease (UCTD), Polymyositis, and Palindromic Rheumatism.

Expertise in
4
conditions
Dr. Thomas Howard
Rheumatology
Expertise in
4
conditions
Dr. Thomas Howard
Rheumatology
Referral may be required

CAMC Rheumatology South Charleston

4610 Kanawha Ave SW Ste 301, 
South Charleston, WV 
 (3.4 miles away)
304-720-8701
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Howard is a Rheumatologist practicing medicine in South Charleston, West Virginia. Dr. Howard is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Sjogren Syndrome, Fibromyalgia, and Psoriatic Arthritis.

Frequently Asked Questions about Dr. Suzanne Gharib

How do I make an appointment with Dr. Suzanne Gharib?

You can book an appointment with Dr. Suzanne Gharib by calling their office at 304-720-8701. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Suzanne Gharib a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Suzanne Gharib is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Suzanne Gharib specialize in?

While Dr. Suzanne Gharib is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Suzanne Gharib participate in research or clinical trials?

Yes. Dr. Suzanne Gharib has published 2 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Suzanne Gharib's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Suzanne Gharib accept my insurance?

Dr. Suzanne Gharib accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 304-720-8701 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gharib's expertise for a condition
ConditionClose
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile